Adalat LA 30 mg Prolonged-Release Tablets

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

지금 구매하세요

Download 환자 정보 전단 (PIL)
16-11-2017
Download 제품 특성 요약 (SPC)
07-10-2014

유효 성분:

Nifedipine

제공처:

PCO Manufacturing Ltd.

ATC 코드:

C08CA; C08CA05

INN (국제 이름):

Nifedipine

복용량:

30 milligram(s)

약제 형태:

Tablet

처방전 유형:

Product subject to prescription which may be renewed (B)

치료 영역:

Dihydropyridine derivatives; nifedipine

승인 상태:

Authorised

승인 날짜:

2001-12-14

환자 정보 전단

                                _ _
_ _
_ _
PACKAGE LEAFLET – INFORMATION FOR THE USER
ADALAT
® LA 30MG PROLONGED RELEASE TABLET
nifedipine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.

Keep this leaflet. You may need to read it again.

If you have more questions, ask your doctor or pharmacist.

This medicine has been prescribed for you.

Do not pass it on to others. It may harm them, even if their symptoms
are the
same as yours.

If any of the side effects gets serious, or if you notice any side
effects not listed in
this leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET
1.
What Adalat LA is
2.
Before you take Adalat LA
3.
How you take Adalat LA
4.
Possible side effects
5.
How to store Adalat LA
6.
Further information
1.
WHAT ADALAT LA IS
Adalat LA contains nifedipine, which belongs to a group of medicines
called _calcium_
_antagonists._
ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA _(chest
pain)._
For high blood pressure: Adalat LA works by relaxing and expanding the
blood
vessels. This makes the blood flow more easily and lowers blood
pressure.
Lower blood pressure reduces the strain on your heart.
For angina: Adalat LA works by relaxing and expanding the arteries
supplying the
heart. This allows more blood and oxygen to reach the heart and
decreases the strain
on it. Your angina attacks will be less severe and less frequent if
there is less strain
on the heart.
2.
BEFORE YOU TAKE ADALAT LA
DO NOT TAKE ADALAT LA:

IF YOU HAVE HAD A HEART ATTACK within the last month.

IF YOU GET A SUDDEN ANGINA ATTACK. Adalat LA will not help relieve
symptoms of
angina quickly.

IF YOU HAVE UNSTABLE ANGINA.

IF YOU ARE ALLERGIC to the active ingredient (nifedipine), to any
other similar
medicines (known as _dihydropyridines) _or to any of the other
ingredients. The
ingredients of Adalat LA are listed in section 6.

IF YOU ARE TAKING RIFAMPICIN, an antibiotic.

IF YOU HAVE A LIVER DISEASE that prevents your liver from working
properly.

IF YOU HAVE INFLAMMATION OF THE
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Adalat LA 30 mg Prolonged-Release Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains 30 mg nifedipine.
Each tablet contains 9.4mg sodium
For a full list of excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release film-coated tablet
_Product imported from The Netherlands, Greece and Spain:_
Pink, lacquered tablets printed ‘Adalat 30’ in black on one side,
plain on the other side.
4 CLINICAL PARTICULARS
As per PA1410/025/006
5 PHARMACOLOGICAL PROPERTIES
As per PA1410/025/006
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
_Excipients present in product imported from The Netherlands and
Spain:_
Tablet core
Polyethylene oxide
Hypromellose
Magnesium stearate
Osmotic Blend
Polyethylene oxide
Sodium chloride
Hypromellose
Iron oxide red (E172)
Magnesium stearate
Organic Coating
Cellulose acetate
Macrogol
Light Protective Coating
Hyprolose
Hypromellose
Propylene glycol
Titanium dioxide (E171)
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_2_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_2_
_1_
_5_
_1_
_9_
_3_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
Iron Oxide, red (E172)
Polish
Hypromellose
Printing ink
Iron oxide black (E172)
The printing ink for product imported from The Netherlands also
includes shellac.
_Excipients present in the product imported from Greece:_
Polyethylene oxide
Hypromellose
Magnesium stearate
Sodium chloride
Iron oxide red (E172)
Cellu
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림